← All trials
NCT00266799
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 13, 2006
- Primary completion
- Sep 29, 2010
- Completion date
- Oct 18, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 210
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- MerckLead sponsor
- Essex PharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.